Healthcare Services

Autoimmune Treatment Market Forecast Analysis Through 2030 With Insights On Industry Expansion

May 27, 2026June 3, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

How Does The Forecasted Market Size Of The Autoimmune Treatment Market Compare Between 2026 And 2030?

The autoimmune treatment market has witnessed considerable expansion in recent years. This market is expected to grow from $8.63 billion in 2025 to $9.84 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 14.0%. Historically, this growth was primarily driven by improved availability of immunosuppressive drugs, the expansion of rheumatology and immunology services, an increase in clinical experience concerning autoimmune care, higher patient diagnosis rates, and broader access to specialty medications.

The autoimmune treatment market is projected to experience substantial expansion in the coming years, with its size reaching $16.53 billion by 2030, driven by a compound annual growth rate (CAGR) of 13.9%. This anticipated growth is primarily attributable to factors such as increasing investment in novel biologics development, an escalating demand for personalized autoimmune therapies, the expansion of digital monitoring and follow-up care, a heightened emphasis on reducing long-term disease complications, and increased research into immune system modulation. Key developments expected during this period include the increasing adoption of biologic therapies, a surge in the use of targeted immunomodulators, the broader integration of long-term disease management programs, the proliferation of personalized treatment regimens, and an enhanced focus on combination drug therapies.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=7863&type=smp

Which Growth Factors Are Strengthening The Autoimmune Treatment Market Landscape?

The expansion of the autoimmune treatment market is expected to be driven by the escalating healthcare expenditures. These expenditures cover all expenses linked to delivering health services, initiatives for family planning, nutritional programs, and urgent medical aid, all focused on health. A surge in healthcare spending would pave the way for the development of more effective treatments and advanced medical technologies for autoimmune conditions. For instance, projections from the Office for Budget Responsibility (OBR) and Treasury show that the UK’s anticipated health expenditure is set to climb to £192 billion ($244.43 billion) in 2024/25, an increase from £182 billion ($231.70 billion) in 2022/23. Similarly, the National Health Expenditures Accounts (NHEA) from KFF, a US-based independent health policy research organization, indicates that health spending in the United States is projected to grow by 5% from 2023 to 2024, reaching $4.9 trillion. Therefore, the upward trend in healthcare expenditures is a key factor propelling the growth of the autoimmune treatment market.

How Is The Autoimmune Treatment Market Examined Through Segment Analysis?

The autoimmune treatment market covered in this report is segmented –

1) By Service Type: Consultation And Diagnosis, Therapy And Monitoring, Drug development

2) By Disease: Rheumatoid Arthritis, Systemic Lupus Erythematosus, Sjögren’s Syndrome, Thyroiditis, Scleroderma, Other Diseases

3) By Application: Disease Management and Symptom Control, Disease Diagnosis and Monitoring, Immune Modulation and Targeted Therapy, Long-Term Care and Relapse Prevention

Subsegments:

1) By Consultation and Diagnosis: Clinical Evaluation and Medical Consultation, Autoimmune Biomarker Testing and Serological Assays, Imaging and Functional Diagnostic Services, Disease Severity Assessment and Risk Stratification

2) By Therapy and Monitoring: Pharmacological Treatment Management, Biologic and Immunotherapy Administration, Disease Activity Monitoring and Follow-Up Services, Adverse Event and Safety Monitoring, Patient Support and Adherence Programs

3) By Drug Development: Preclinical Research and Target Identification, Clinical Trial Services (Phase I–IV), Regulatory Affairs and Compliance Services, Pharmacovigilance and Post-Marketing Surveillance

Which Trends Are Influencing The Expansion Of The Autoimmune Treatment Market?

Leading companies in the autoimmune treatment market are increasingly concentrating on implementing advanced clinical trial platforms to secure a competitive edge. These pioneering clinical trial platforms in autoimmune treatment employ sophisticated technologies and individualized strategies to boost effectiveness, safety, and patient results. For example, in August 2023, the Scleroderma Research Foundation, a US-based non-profit organization, unveiled the CONQUEST trial platform. The CONQUEST program is dedicated to advancing research and developing treatments for scleroderma, a rare autoimmune disease affecting connective tissues. It addresses significant challenges in clinical development and supports progress in scleroderma therapeutics. The CONQUEST platform clinical trial marks a first in rare autoimmune diseases, specifically engineered to swiftly assess potential treatments for interstitial lung disease associated with systemic sclerosis (SSc-ILD) and overall SSc outcomes, encompassing those related to skin and other facets of the illness.

Who Are The Businesses Driving Activity In The Autoimmune Treatment Market?

Major companies operating in the autoimmune treatment market are Abbott Laboratories, Amgen Inc., Eli Lilly and Company, Pfizer Inc., F Hoffmann-La Roche AG, AstraZeneca PLC, Bristol-Myers Squibb Company, Thermo Fisher Scientific Inc., Biogen Idec Inc., GSK PLC, Genentech Inc., AbbVie Inc., Celgene Corporation, Gilead Sciences Inc., Merck & Co. Inc., Novartis International AG, Sanofi SA, Takeda Pharmaceutical Company Limited, Teva Pharmaceutical Industries Ltd., UCB SA, Alexion Pharmaceuticals Inc., AnaptysBio Inc., Apellis Pharmaceuticals Inc., Arena Pharmaceuticals Inc., Aurinia Pharmaceuticals Inc., BioCryst Pharmaceuticals Inc., Cabaletta Bio Inc., ChemoCentryx Inc., Corbus Pharmaceuticals Holdings Inc., CSL Limited

Access The Complete Autoimmune Treatment Market Report:

https://www.thebusinessresearchcompany.com/report/autoimmune-treatment-global-market-report

Which Region Has The Strongest Presence In The Autoimmune Treatment Market?

North America was the largest region in the autoimmune treatment market in 2025. The regions covered in the autoimmune treatment market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access Autoimmune Treatment Market Report for Deeper Competitive Insights

https://www.thebusinessresearchcompany.com/customise?id=7863&type=smp

Browse Through More Reports Similar to the Global Autoimmune Treatment Market 2026, By The Business Research Company

Autoimmune Disease Diagnosis Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/autoimmune-disease-diagnosis-global-market-report

Veterinary Autoimmune Disease Therapeutics Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/veterinary-autoimmune-disease-therapeutics-global-market-report

Systemic Lupus Erythematosus Treatment Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/systemic-lupus-erythematosus-treatment-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795